Cargando…
Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs
Metal complexes have gradually been attracting interest from researchers worldwide as potential cancer therapeutics. Driven by the many side effects of the popular platinum-based anticancer drug cisplatin, the tireless endeavours of researchers have afforded strategies for the design of appropriate...
Autores principales: | Sharma S., Ajay, N., Vaibhavi, Kar, Binoy, Das, Utpal, Paira, Priyankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281374/ https://www.ncbi.nlm.nih.gov/pubmed/35919594 http://dx.doi.org/10.1039/d2ra03434d |
Ejemplares similares
-
Rhenium Tricarbonyl Complexes of Azodicarboxylate Ligands
por: Jordan, Rose, et al.
Publicado: (2022) -
Substitution reactivity and structural variability induced by tryptamine on the biomimetic rhenium tricarbonyl complex
por: Jacobs, Frederick J. F., et al.
Publicado: (2021) -
Ru(ii)arene(N^N bpy/phen)-based RAPTA complexes for in vitro anti-tumour activity in human glioblastoma cancer cell lines and in vivo toxicity studies in a zebrafish model
por: P. K., Anuja, et al.
Publicado: (2022) -
Different routes for the construction of biologically active diversely functionalized bicyclo[3.3.1]nonanes: an exploration of new perspectives for anticancer chemotherapeutics
por: Roy, Nilmadhab, et al.
Publicado: (2023) -
Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy
por: Liew, Hui Shan, et al.
Publicado: (2020)